Inhibrx Biosciences INBX
NASDAQ INBX
$90.44 -0.17 (-0.19%)
As of: Nov 11, 2026 · 3:16 PM EST

Inhibrx Biosciences (INBX) Selling, General & Administrative (2023 - 2026)

Updated

Analysis

Inhibrx Biosciences (INBX) Selling, General & Administrative (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Inhibrx Biosciences 1.33 Bn 760.41 Mn - 8.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.25 Mn
Mar 31, 2026 5.71 Mn
Dec 31, 2025 5.57 Mn
Sep 30, 2025 5.28 Mn
Jun 30, 2025 6.42 Mn
Mar 31, 2025 6.02 Mn
Dec 31, 2024 16.66 Mn
Sep 30, 2024 7.90 Mn
Jun 30, 2024 93.37 Mn
Mar 31, 2024 9.97 Mn
Dec 31, 2023 7.83 Mn
Sep 30, 2023 7.89 Mn
Jun 30, 2023 7.26 Mn
API Access

Inhibrx Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=INBX&period=max&api_key=YOUR_API_KEY